Bruker breaks annual sales record in spite of lower Q4 profits | Earnings roundup

MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.

Here’s a quick rundown of a few releases over the past couple days:

Bruker breaks annual sales record in spite of lower Q4 profits
Bruker Corp. (NSDQ:BRKR) reported profits of $29.3 million, or 18 cents per diluted share, on sales of $416.1 million during the three months ended Dec. 31. That compares with profits of $43.5 million, or 26 cents per diluted share, on sales of $366.4 million during the same period last year.

Full-year profits were $95.4 million, or 58 cents per diluted share, on sales of $1.30 billion. That compares with profits of $81.2 million, or 49 cents per diluted share, on sales of $1.11 million in 2009.
Read more

Fresenius profits rise 10 percent after sales bump
Fresenius Medical Care AG & Co. (NSDQ:FMS) reported profits of $271.3 million, or 90 cents per diluted share, on sales of $3.17 billion during the three months ended Dec. 31, 2010. That compares with profits of $246.6 million, or 82 cents per diluted share, on sales of $3.04 billion during the same period in 2009.

Full-year profits were $978.5 million, or $3.25 per diluted share, on sales of $12.05 billion. That compares with profits of $891.1 million, or $2.99 per diluted share, on sales of $11.25 billion in 2009.
Read more

Volcano Q4 losses ease as sales jump 14 percent
Volcano Corp. (NSDQ:VOLC) reported a loss of $1.7 million, or 3 cents per diluted share, on sales of $81.2 million during the three months ended Dec. 31. That compares with a loss of $12.1 million, or 25 cents per diluted share, on sales of $71.0 million during the same period in 2009.

Full-year profits were $5.2 million, or 10 cents per diluted share, on sales of $294.1 million. That compares with losses of $29.0 million, or 60 cents per diluted share, on sales of $227.9 million in 2009.
Read more

Synovis Q1 profits almost triple
Synovis Life Technologies Inc. (NSDQ:SYNO) reported profits of $1.8 million or 16 cents per diluted share, on sales of $19.5 million during the three months ended Jan. 31. That compares with profits of $643,000, or 6 cents per diluted share, on sales of $15.2 million during the same period last year.
Read more